Skip Navigation

AIDSInfo-at-a-glance

Issue No. 21 | May 20, 2011
A Service of the U.S. Department of Health and Human ServicesView HTML version
News and Features 

FDA Approves Rilpivirine (Edurant), a New NNRTI, for the Treatment of HIV in Treatment-Naive Patients

“On Friday, May 20, 2011, FDA approved Edurant (rilpivirine) 25 mg tablets, a new non-nucleoside reverse transcriptase inhibitor (NNRTI) for the treatment of HIV. Rilpivirine is an antiviral drug that helps to block reverse transcriptase, an enzyme necessary for HIV replication. The recommended dose of rilpivirine is one 25 mg tablet once daily taken orally with a meal.”

The label will be available at the FDA Web site.

More information is available:

AIDSinfo Updates the HIV/AIDS Glossary Application!

AIDSinfo has released an updated version of the HIV/AIDS Glossary App for iPhone, iPod touch, and iPad! Based on the popular AIDSinfo Glossary of HIV/AIDS-Related Terms, the application provides on-the-go access to definitions for more than 850 HIV/AIDS-related terms. The updated app still provides popular search features in both English and Spanish, but has been expanded to include:

  • New audio pronunciation of select terms
  • Improved design for intuitive navigation
  • Optimization for use on the iPad

Download the newest version of the AIDSinfo Glossary App free from the Apple iTunes store. And Android users, look for the AIDSinfo Glossary App to be available for your devices later this year. 

AIDSinfo welcomes feedback about the updated glossary application. Please send comments or questions to ContactUs@aidsinfo.nih.gov.

More information is available:

NIAID Director Dr. Anthony Fauci to Speak About 30th Anniversary of HIV/AIDS

“On June 5, 1981, the first published description of a mysterious illness involving five young, previously healthy gay men appeared in the CDC publication Morbidity and Mortality Weekly Report (MMWR). The cases marked the first recognition of what is now known as AIDS, a disease that has claimed the lives of more than 30 million people worldwide since that first report 30 years ago.

“NIAID director Dr. Anthony Fauci, who has been closely involved in the fight against HIV/AIDS since it began, will describe his personal experiences as a physician, HIV/AIDS researcher and scientific administrator at a lecture to commemorate the 30th anniversary of the MMWR report. It will take place on Tuesday, May 31, from 2 to 3 p.m. in Lipsett Amphitheater, Bldg. 10. It also will be webcast at http://videocast.nih.gov. ...

“Fauci will describe how relationships he forged with gay activists helped advance HIV treatments and led to an accelerated drug approval pathway that still exists today; his experiences with five successive White House administrations over the course of the pandemic; the advances in HIV treatment that have turned an almost certain death sentence into what is now for many a manageable chronic health condition; progress and continued research to find new ways to prevent HIV infection and, ultimately, a cure; and the challenges that remain.”

More information is available:

Home | Guidelines | Clinical Trials | Drugs | Health Topics | Education Materials | Mobile Resources & Tools
Unsubscribe | Contact Us
Left footer corner image Left footer corner image